{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:25:41Z","timestamp":1792070741555,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Swedish Cancer Society"},{"name":"Bengt Ihre fund"},{"name":"LMK Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bpg.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T03:00:51Z","timestamp":1424055651000},"page":"221-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":331,"title":["Epidemiology of cholangiocarcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Annika","family":"Bergquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"von Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2015.02.003_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/MCG.0b013e31802f3132","article-title":"Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population-based study","volume":"41","author":"Shaib","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"42","key":"10.1016\/j.bpg.2015.02.003_bib4","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.3748\/wjg.14.6458","article-title":"Cholangiocarcinoma: a compact review of the literature","volume":"14","author":"Ustundag","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.bpg.2015.02.003_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2015.02.003_bib6","series-title":"International classification of diseases for oncology: ICD-O","year":"2000"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-3156.2004.01234.x","article-title":"Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand","volume":"9","author":"Sriamporn","year":"2004","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib11","first-page":"475","article-title":"Cancer incidence in Thailand, 1988\u20131991","volume":"4","author":"Vatanasapt","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.critrevonc.2008.09.008","article-title":"Cholangiocarcinoma","volume":"69","author":"Mosconi","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.bpg.2015.02.003_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gcb.2010.01.008","article-title":"Cholangiocarcinoma: descriptive epidemiology and risk factors","volume":"34","author":"de Martel","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.bpg.2015.02.003_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.dld.2009.10.009","article-title":"Descriptive epidemiology of cholangiocarcinoma in Italy","volume":"42","author":"Alvaro","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.bpg.2015.02.003_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3109\/00365521.2011.589472","article-title":"Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany","volume":"46","author":"von Hahn","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib24","first-page":"193","article-title":"Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan","volume":"24","author":"Utada","year":"2014","journal-title":"J\u00a0Epidemiol"},{"issue":"11","key":"10.1016\/j.bpg.2015.02.003_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/djk201","article-title":"Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002","volume":"99","author":"Jepsen","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2010.06.039","article-title":"Trends in the incidence and management of biliary tract cancer: a French population-based study","volume":"54","author":"Lepage","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.bpg.2015.02.003_bib27","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","article-title":"Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification","volume":"59","author":"Tyson","year":"2014","journal-title":"Dig Dis Sci."},{"issue":"15","key":"10.1016\/j.bpg.2015.02.003_bib28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3748\/wjg.14.2297","article-title":"Opisthorchiasis in Thailand: review and current status","volume":"14","author":"Kaewpitoon","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jhbp.62","article-title":"Roles of liver fluke infection as risk factor for cholangiocarcinoma","volume":"21","author":"Sithithaworn","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreatic Sci"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000268109","article-title":"Management of congenital bile duct cysts","volume":"27","author":"Mabrut","year":"2010","journal-title":"Dig Surg"},{"issue":"12","key":"10.1016\/j.bpg.2015.02.003_bib32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/bjs.4815","article-title":"Bile duct cysts in adults","volume":"91","author":"Soreide","year":"2004","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/archsurg.1995.01430020084016","article-title":"Current management and long-term prognosis of hepatolithiasis","volume":"130","author":"Chijiiwa","year":"1995","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5009\/gnl.2013.7.4.475","article-title":"Incidence of cholangiocarcinoma with or without previous resection of liver for hepatolithiasis","volume":"7","author":"Lee","year":"2013","journal-title":"Gut Liver"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/BF01296436","article-title":"Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study","volume":"37","author":"Su","year":"1992","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bpg.2006.05.009","article-title":"Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)","volume":"20","author":"Tazuma","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/bjc.2011.607","article-title":"Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma","volume":"106","author":"Nordenstedt","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2015.02.003_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.22283","article-title":"Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study","volume":"120","author":"Welzel","year":"2007","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jvh.12093","article-title":"The role of the hepatitis viruses in cholangiocarcinoma","volume":"20","author":"Ralphs","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2015.02.003_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.bpg.2015.02.003_bib44","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1440-1746.2012.07207.x","article-title":"Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review","volume":"27","author":"Li","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"9","key":"10.1016\/j.bpg.2015.02.003_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10654-009-9365-4","article-title":"Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978\u20132003","volume":"24","author":"Erichsen","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.bpg.2015.02.003_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.bpg.2015.02.003_bib51","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000128169","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience","volume":"25","author":"Morris-Stiff","year":"2008","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib53","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib54","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"9","key":"10.1016\/j.bpg.2015.02.003_bib55","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.humpath.2014.05.008","article-title":"Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma","volume":"45","author":"Kerr","year":"2014","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1091-255X(99)80051-1","article-title":"Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis","volume":"3","author":"Ahrendt","year":"1999","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib59","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510230526","article-title":"Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation","volume":"23","author":"Nashan","year":"1996","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib60","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib61","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2014.07.032","article-title":"Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET","volume":"61","author":"Sangfelt","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.bpg.2015.02.003_bib63","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib64","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"4 Pt 1","key":"10.1016\/j.bpg.2015.02.003_bib65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.1840120421","article-title":"Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures","volume":"12","author":"Rabinovitz","year":"1990","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.bpg.2015.02.003_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Navaneethan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.bpg.2015.02.003_bib67","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib68","first-page":"254","article-title":"Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"35","author":"von Seth","year":"2015","journal-title":"Liver Int Off J Int Assoc Study of the Liver"},{"issue":"12","key":"10.1016\/j.bpg.2015.02.003_bib69","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1055\/s-0032-1325677","article-title":"Risk factors for complications of ERCP in primary sclerosing cholangitis","volume":"44","author":"Ismail","year":"2012","journal-title":"Endoscopy"},{"issue":"4","key":"10.1016\/j.bpg.2015.02.003_bib70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib73","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.bpg.2015.02.003_bib74","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365521.2010.533384","article-title":"Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results","volume":"46","author":"Friman","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib76","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/145749691110000106","article-title":"Cholangiocarcinoma\u2013current treatment options","volume":"100","author":"Friman","year":"2011","journal-title":"Scand J Surg"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the L","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2015.02.003_bib79","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.bpg.2015.02.003_bib80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.bpg.2015.02.003_bib81","first-page":"1048","article-title":"Risk factors for perihilar cholangiocarcinoma: A hospital-based case-control study","volume":"35","author":"Lee","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"10","key":"10.1016\/j.bpg.2015.02.003_bib82","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control CCC"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T02:23:06Z","timestamp":1537842186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691815000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1521691815000190"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2015.02.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}